INS and cancer: To accomplish this aim, a collection of initial glycemic biomarkers (hyperglycemia, insulin secretion, insulin resistance, etc.)were analyzed for independent associations with long-term cancer outcomes within a nationally representative sample assembled from the Third National Health and Nutrition Examination Survey (NHANES III).